Clinical trial
Novel Therapies for Metabolic Complications of Lipodystrophies
NCT00457938 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00457938 |
|---|---|
| Title | Novel Therapies for Metabolic Complications of Lipodystrophies |
| Official title | Novel Therapies for Metabolic Complications in Patients With Lipodystrophies |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | National Institutes of Health (NIH) NIH Takeda Industry Amylin Pharmaceuticals, LLC. |
| Status | Completed |
| Study type | Interventional |
| Conditions | Insulin Resistance, Hypertriglyceridemia, Diabetes, Hepatic Steatosis |
| Intervention type | Other |
| Interventions | low-fat diet ( Still recruiting ), Diet |
| Enrollment | 4 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | Apr 9, 2007 |
| Last update posted | Oct 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: